By using membrane preparations from B. licheniformis, this enzyme has been assayed in both directions and found to be resistant to tunicamycin (1OOpg. ml-').
Therefore in wall-polymer assembly in B. licheniformis, B. subtilis and S . aureus tunicamycin has been shown to inhibit the biosynthesis of both peptidoglycan and the linkage units involved in the attachment of teichoic acids to peptidoglycan. Although in B. licheniformis a 5-fold difference was observed in the concentration of tunicamycin required to inhibit the two translocases, the known structural role of peptidoglycan points to inhibition of the synthesis of this polymer being responsible for the observed antibacterial activity. If, as suggested (Heifetz et al., 1979) , tunicamycin acts as a substrate-product transition-state analogue binding irreversibly to sensitive enzymes, then the differences observed in the concentration of antibiotic required to inhibit the sensitive translocases in B. licheniformis may be a reflection of the affinity of tunicamycin for the two active sites.
Finally, when considering the action of tunicamycin in terms of the experimental results obtained in bacteria, yeast and mammalian systems, the following common features become apparent. All the sensitive enzymes, with the possible exception of the one involved in the incorporation of N-acetylglucosamine into the linkage unit of M . luteus teichuronic acid (Rohr et al., 1977; Weston & Perkins, 1977) , appear to involve the translocation of phospho-N-acetylglucosamine or its derivatives to a lipid acceptor. In this context phospho-N-acetylmuramoyl-pentapeptide can be regarded as a peptide-substituted 3-0-lactyl ether of Nacetylglucosamine. The amphipathic character of tunicamycin may be of major importance in the recognition of the polyprenyl phosphate acceptor in its membrane environment. Perhaps more surprising is the finding that, although the majority if not all of the sensitive enzymes catalyse the transfer of phos- During the past 5 years, use of the antibiotic tunicamycin has led to an appreciation of the importance of lipid intermediates in protein glycosylation, and also to a greater insight into the biological functions of the glycoproteins formed.
The early studies that provided the evidence for the transfer of pre-formed oligosaccharide from a lipid carrier (dolichol pyrophosphate) to protein were generally carried out using microsomal fractions of the tissue under investigation. The glycosylated proteins thus formed were usually bound to the microsomal membranes and in most cases did not appear to correspond to any of the major glycoproteins characteristic of the particular tissues studied [see Waechter & Lennarz (1976) for review].
Undisrupted cells or tissues, being active in protein synthesis, were found to be more useful than microsomal preparations for the study of the glycosylation of specific proteins. Tunicamycin inhibits the synthesis of lipid-linked oligosaccharide by blocking the transfer of N-acetylglucosamine phosphate from UDP-N-acetylglucosamine to dolichol phosphate (Lehle & Tanner, 1976) . By observing the effect of tunicamycin on protein glycosylation in undisrupted cells, a number of investigators have provided evidence for the transfer of oligosaccharide from dolichol pyrophosphate to specific proteins. For example, Struck & Lennarz (1977) reported that the incorporation of mannose and N-acetylglucosamine into ovalbumin by hen oviduct slices was inhibited by tunicamycin, suggesting that this protein is glycosylated via lipid-linked intermediates.
The mammary gland of the lactating rabbit is a useful system in which to evaluate the importance of the lipid intermediate pathway in protein glycosylation, because of both the quantity and the variety of glycoproteins produced by this tissue. Casein, the major protein secreted by the mammary gland, is a glycoprotein containing galactose, galactosamine and sialic acid (Al-Sarraj et al., 1978). Another milk protein, a-lactalbumin, is known to be glycosylated in some species (Brown et al., 1977; Barman, 1970) . In addition, it is likely that the rate of synthesis of cell-surface glycoproteins will be especially high in the mammary gland owing to the continual loss of plasma membrane during the formation of the milk-fat globule.
The presence of lipid-linked sugars in rabbit mammary tissue was first reported by White (1977, 1978) , in a microsomal preparation. This system was found to catalyse the incorporation of mannose from GDP-[U-l4C1mannose into dolichol phosphate mannose, dolichol diphosphate oligosaccharide and endogenous protein. Evidence was obtained for the existence of a precursor-product relationship between these three components, suggesting that mannose is transferred to protein via the lipid-linked intermediates. The incorporation of mannose into protein was, however, extremely low, and characterization of these glycosylated proteins was not possible.
The rate of protein glycosylation in undisrupted mammary tissue was found to be much higher than in the microsomal preparation (Speake & White, 1978a) . This is probably due to the fact that the undisrupted tissue is actively synthesizing 586th MEETING. BRISTOL proteins, thus providing a continuous supply of substrates available for glycosylation. ~-[2-'HIMannose and N-acetyl-D-[ l-14C]glucosamine were incorporated by mammary explants into a group of polypeptides with molecular weights in the range 40000-80000, as determined by polyacrylamide-gel electrophoresis. Radioactivity from N-aCety1-D-l 1-14C]glucosamine was also incorporated into a polypeptide of mo1.w. 32000, which was identified as casein by immunoprecipitation with casein-specific antibody (Speake & White, 1979~) . It was concluded that mammary explants incorporate label from N-acetyl-D-[ l-14Clglucosamine into casein after conversion of some of the initial precursor to N-acetylgalactosamine, since the latter sugar was the only radioactive compound released from the casein by acid hydrolysis (Speake & White, 1979~) .
Mammary explants were also found to synthesize a lipidlinked oligosaccharide consisting of 10-12 monosaccharide units and containing mannose, N-acetylglucosamine and glucose (Speake & White, 1978a,b) . The most probable structure of this compound is dolichol-P-P-[GlcNAc*l *[Man l,-,[Glcl,.
The results discussed so far in this paper indicate that mammary explants incorporate radiolabelled sugars into a lipidlinked oligosaccharide and into glycoproteins. They do not, however, provide any direct evidence that the lipid-linked oligosaccharide acts as an intermediate in protein glycosylation in the explant system. No suggestion of a precursor-product relationship between the lipid-linked oligosaccharide and glycoprotein is evident from the kinetics of sugar incorporation (Speake & White, 1978~) . Furthermore, it was impossible to obtain meaningful results from pulse-chase experiments owing to the inability to remove labelled sugar nucleotidcs from the explants (B. K. Speake & D. A. White, unpublished observations). It was only with the use of tunicamycin that we were able to obtain firm evidence that the lipid-linked oligosaccharide is an intermediate in the glycosylation of a number of mammary polypeptides (Speake & White, 1977 .
In the presence of tunicamycin (20pg/ml), the incorporation of mannose into lipid-linked oligosaccharide was inhibited by approx. 7096. The failure to inhibit this process completely is probably due to an inability of the tunicamycin to enter into some of the cells in the interior of the explant. The incorporation of mannose into protein was inhibited by tunicamycin to the same extent as was the incorporation into lipid-linked oligosaccharide. Protein synthesis was only slightly decreased in the presence of tunicamycin. These results strongly suggest that the majority of mannose residues present in mammary glycoproteins are incorporated via the lipid-intermediate pathway.
The incorporation of radioactivity from N-acetyl[14C lglucosamine into the lipid-linked oligosaccharide was inhibited by 70% in the presence of tunicamycin, whereas the incoporation into protein was only inhibited by 30%. The reason for this apparent discrepancy is the fact that considerable conversion of the initial labelled precursor to N-acetylgalactosamine occurs in the explant, and this latter sugar is incorporated into mammary proteins (largely casein) by a tunicamycin-insensitive route.
In the absence of tunicamycin, 50-70% of the radioactivity incorporated from N-acetyl[ l-14Clglucosamine into protein was present as N-acetylgalactosamine. Tunicamycin severely inhibited the incorporation of N-acetylglucosamine into protein, but had no effect on the incorporation of N-acetylgalactosamine.
Analysis of the labelled proteins by polyacrylamide-gel electrophoresis revealed that the incorporation of mannose and N-acetylglucosamine into the majority of the polypeptides with mol.wts. in the range 40000-80000 was inhibited by tunicamycin. The lipid-linked oligosaccharide is thus implicated in the glycosylation of these polypeptides. Presumably the linkage between these polypeptides and the carbohydrate moiety is of the N-glycosidic type.
* Abbreviations: GlcNAc, N-acetylglucosamine; Man, mannose.
The incorporation of labelled N-acetylgalactosamine (derived from N-acetylf 1-14Clglucosamine into casein was not affected by tunicamycin. Casein is a glycoprotein in which the linkage between the polypeptide chain and the carbohydrate moiety is of the 0-glycosidic type, and is glycosylated by sequential transfer of monosaccharide residues, without the participation of lipid-linked intermediates.
By inhibiting protein synthesis with cycloheximide and observing the subsequent effect on saccharide incorporation into protein, we have obtained some information on the timing of protein glycosylation with respect to the synthesis of the polypeptides (Speake & White, 19796) . Addition of cycloheximide brought about an immediate cessation of the incorporation of mannose into explant protein. This result suggests that mannose-containing oligosaccharide is transferred from the lipid carrier to newly synthesized protein. There is evidence in other systems that glycosylation may occur on nascent polypeptide chains that are still attached to ribosomes (Kiely et al., 1976) . In contrast, the incorporation of label from N-acetyl-[ l-14C]glucosamine into protein was not greatly inhibited until approx. 30 min after addition of cycloheximide. This observation was interpreted as being the result of conversion of a large proportion of the labelled precursor to N-acetylgalactosamine, which is subsequently incorporated into casein. It thus seems likely that the glycosylation of casein occurs some time after synthesis of the casein polypeptides, presumably in the Golgi region of the cell.
A transient increase in the incorporation of mannose into lipid-linked oligosaccharide was observed in the presence of cycloheximide, suggesting that in the absence of newly synthesized polypeptides, the oligosaccharide accumulates on the lipid carrier. Subsequently, a decrease in the amount of radioactive label present in the lipid-linked oligosaccharide was found to occur, probably owing to degradation of the oligosaccharide by glycosidases. In support of this view, the size of the lipid-linked oligosaccharide extracted from explants incubated for 2 h in the presence of cycloheximide was considerably smaller than that synthesized in the absence of the inhibitor.
On the basis of these results, it is possible to suggest a simple model to describe protein glycosylation in mammary tissue. In this model, casein is glycosylated, probably in the Golgi, by sequential transfer of monosaccharide units from nucleotide sugars to the protein. A number of other polypeptides, including the group with apparent mol.wts. in the range 40000-80000, are glycosylated either during or soon after their synthesis, by transfer of an oligosaccharide from dolichol pyrophosphate. The identity and function of these polypeptides is, as yet, unknown. It was observed that, after 5 h in the presence of tunicamycin, the explants were beginning to disaggregate, suggesting that some of the proteins that are glycosylated via lipid-linked intermediates may be involved in intercellular adhesion (B. K. Speake & D. A. White, unpublished observations) .
The presence of covalently attached carbohydrate in a large proportion of secreted proteins has led to considerable speculation as to the role of glycosylation in the secretion mechanism. Tunicamycin has been used in a number of systems in attempts to elucidate the relationship between the glycosylation and the secretion of proteins. Hickman & Kornfeld (1978) have demonstrated that glycosylation is a prerequisite for the secretion of certain immunoglobulins by mouse plasmacytoma cells. In contrast, tunicamycin had no effect on the secretion of transferrin and very-low-density lipoprotein by hepatocytes (Struck et al., 1978) .
The fungus Aspergillus niger secretes a number of glycosidases into the culture medium. Several of these enzymes have been shown to be glycoproteins (Adya & Elbein, 1977) . In the presence of tunicamycin (40pg/ml), the activities of B-N-acetylglucosaminidase, a -galactosidase and p-glucosidase in the culture medium were decreased by approx. 70% (Speake et al., 1979) . The intracellular activities of these enzymes were also inhibited (by approx. 50%) during culture in the presence of tunicamy cin.
Mycelia of A. niger were incubated for 24 h in the presence of ~-[2-%]mannose. The radiolabelled proteins secreted into the culture medium were separated by polyacrylamide-gel electrophoresis. The results indicated that, in the presence of tunicamycin, the glycosylation of proteins that have the same electrophoretic mobility as the three glycosidases is inhibited (Speake et al., 1979) .
Antiserum specific for /?-N-acetylglucosaminidase was obtained after injection of the purified enzyme into rabbits. Immunotitration of the enzyme activity in the culture medium indicated that the decreased enzyme activity observed in the presence of tunicamycin was due to a decrease in the amount of immunodetectable enzyme (B. K. Speake, D. J. Malley & F. W. Hemming, unpublished work) .
There are a number of possible explanations for the decreased amount of enzyme in the culture medium during growth of A. niger in the presence of tunicamycin. Inhibition of glycosylation of the newly synthesized enzyme may lead to impairment of its secretion. No intracellular accumulation of /%N-acetylglucos aminidase was, however, observed. Secondly, it is possible that the non-glycosylated enzyme may be especially susceptible to proteolytic degradation, either before or after secretion from the cell. Finally, inhibition of the synthesis of the protein portion of the specific enzyme has not been ruled out, although tunicamycin was found to have little effect on total protein synthesis. Obviously more work is needed to distinguish between these alternative explanations. It is however evident that glycosylation is of considerable functional importance in the production of secreted enzyme by this organism.
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